CVE-2026-42933

CVE-2026-42933 is a critical-severity vulnerability with a CVSS 3.x base score of 10.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-441.

Key facts

Description

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Frequently asked questions

What is CVE-2026-42933?
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
How severe is CVE-2026-42933?
CVE-2026-42933 has a CVSS 3.x base score of 10.0, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-42933 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2026-42933?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2026-42933 published?
CVE-2026-42933 was published on 2026-07-23 and last updated on 2026-07-27.

References

Other CWE-441 vulnerabilities

Browse all CWE-441 vulnerabilities →